{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:06:58Z","timestamp":1784070418599,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.xkme.2025.101237","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T15:55:23Z","timestamp":1767455723000},"page":"101237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Impact of Tenapanor on Serum Phosphate in Adult Dialysis Patients: A Narrative Review"],"prefix":"10.1016","volume":"8","author":[{"given":"Malki","family":"Waldman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephani","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Newkirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey","family":"Hawes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Byham-Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.xkme.2025.101237_bib2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2215\/CJN.06080809","article-title":"Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease","volume":"5","author":"Kalantar-Zadeh","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.xkme.2025.101237_bib3","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2215\/CJN.09750913","article-title":"Renal control of calcium, phosphate, and magnesium homeostasis","volume":"10","author":"Blaine","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.xkme.2025.101237_bib4","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/sdi.12439","article-title":"Removal of phosphorus by hemodialysis","volume":"28","author":"Daugirdas","year":"2015","journal-title":"Semin Dial"},{"issue":"20","key":"10.1016\/j.xkme.2025.101237_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012223","article-title":"Mineral bone disorders in kidney disease patients: the ever-current topic","volume":"23","author":"Hu","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.xkme.2025.101237_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3390\/nu9020095","article-title":"Dietary sources of phosphorus among adults in the United States: results from NHANES 2001\u20132014","volume":"9","author":"McClure","year":"2017","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/j.xkme.2025.101237_bib7","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1093\/ndt\/gft244","article-title":"Phosphate control in end-stage renal disease: barriers and opportunities","volume":"28","author":"Waheed","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"10.1016\/j.xkme.2025.101237_bib8","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.ekir.2023.10.001","article-title":"Tenapanor as add-on treatment for hyperphosphatemia in dialysis patients: enough bang for the buck?","volume":"8","author":"Wish","year":"2023","journal-title":"Kidney Int Rep"},{"issue":"73","key":"10.1016\/j.xkme.2025.101237_bib9","first-page":"20369","article-title":"Department of Health and Human Services. Medicare and Medicaid programs; conditions for coverage for end-stage renal disease facilities. Final rule","volume":"73","year":"2008","journal-title":"Fed Regis"},{"issue":"3 suppl 1","key":"10.1016\/j.xkme.2025.101237_bib10","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.ajkd.2020.05.006","article-title":"KDOQI clinical practice guideline for nutrition in CKD: 2020 update","volume":"76","author":"Ikizler","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.xkme.2025.101237_bib11","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.34067\/KID.0000000000000262","article-title":"Managing phosphate burden in patients receiving dialysis: beyond phosphate binders and diet","volume":"4","author":"Kalantar-Zadeh","year":"2023","journal-title":"Kidney360"},{"issue":"4","key":"10.1016\/j.xkme.2025.101237_bib12","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ekir.2022.01.1055","article-title":"Past, present, and future of phosphate management","volume":"7","author":"Doshi","year":"2022","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.xkme.2025.101237_bib13","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9457440","article-title":"Phosphate frustration: treatment options to complement current therapies","volume":"2022","author":"Pergola","year":"2022","journal-title":"Int J Nephrol"},{"issue":"8","key":"10.1016\/j.xkme.2025.101237_bib14","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ekir.2019.06.002","article-title":"Strategies for phosphate control in patients with CKD","volume":"4","author":"Barreto","year":"2019","journal-title":"Kidney Int Rep"},{"issue":"1","key":"10.1016\/j.xkme.2025.101237_bib15","first-page":"10","article-title":"Phosphate binders in patients with chronic kidney disease","volume":"40","author":"Chan","year":"2017","journal-title":"Aust Prescr"},{"issue":"9","key":"10.1016\/j.xkme.2025.101237_bib16","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1016\/j.ekir.2021.06.030","article-title":"Effect of tenapanor on phosphate binder pill burden in hemodialysis patients","volume":"6","author":"Akizawa","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"10","key":"10.1016\/j.xkme.2025.101237_bib17","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.34067\/KID.0002002021","article-title":"Safety and efficacy of tenapanor for long-term serum phosphate control in maintenance dialysis: a 52-week randomized phase 3 trial (PHREEDOM)","volume":"2","author":"Block","year":"2021","journal-title":"Kidney360"},{"issue":"4","key":"10.1016\/j.xkme.2025.101237_bib18","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1681\/ASN.2018080832","article-title":"Efficacy and safety of tenapanor in patients with hyperphosphatemia receiving maintenance hemodialysis: a randomized phase 3 trial","volume":"30","author":"Block","year":"2019","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2025.101237_bib19","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfad216","article-title":"Tenapanor in Chinese ESRD patients with hyperphosphatemia on haemodialysis: a randomised, phase 3 trial","volume":"17","author":"Gan","year":"2023","journal-title":"Clin Kidney J"},{"issue":"2","key":"10.1016\/j.xkme.2025.101237_bib20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ekir.2021.11.008","article-title":"Dose-response of tenapanor in patients with hyperphosphatemia undergoing hemodialysis in Japan-A phase 2 randomized trial","volume":"7","author":"Inaba","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"1","key":"10.1016\/j.xkme.2025.101237_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-45080-9","article-title":"Long-term safety and decrease of pill burden by tenapanor therapy: a phase 3 open-label study in hemodialysis patients with hyperphosphatemia","volume":"13","author":"Koiwa","year":"2023","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.xkme.2025.101237_bib22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10157-023-02406-1","article-title":"Tenapanor for peritoneal dialysis patients with hyperphosphatemia: a phase 3 trial","volume":"28","author":"Nakayama","year":"2024","journal-title":"Clin Exp Nephrol"},{"issue":"11","key":"10.1016\/j.xkme.2025.101237_bib23","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.ekir.2023.08.003","article-title":"Randomized study of tenapanor added to phosphate binders for patients with refractory hyperphosphatemia","volume":"8","author":"Nitta","year":"2023","journal-title":"Kidney Int Rep"},{"issue":"6","key":"10.1016\/j.xkme.2025.101237_bib24","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1681\/ASN.2020101398","article-title":"A randomized trial of tenapanor and phosphate binders as a dual-mechanism treatment for hyperphosphatemia in patients on maintenance dialysis (AMPLIFY)","volume":"32","author":"Pergola","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.xkme.2025.101237_bib25","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1159\/000516156","article-title":"Therapeutic effects of add-on tenapanor for hemodialysis patients with refractory hyperphosphatemia","volume":"52","author":"Shigematsu","year":"2021","journal-title":"Am J Nephrol"},{"issue":"11","key":"10.1016\/j.xkme.2025.101237_bib26","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.34067\/KID.0000000000000280","article-title":"Tenapanor improves long-term control of hyperphosphatemia in patients receiving maintenance dialysis: the NORMALIZE study","volume":"4","author":"Silva","year":"2023","journal-title":"Kidney360"},{"issue":"5","key":"10.1016\/j.xkme.2025.101237_bib27","doi-asserted-by":"crossref","first-page":"732","DOI":"10.34067\/KID.0000000000000387","article-title":"Tenapanor as therapy for hyperphosphatemia in maintenance dialysis patients: results from the OPTIMIZE study","volume":"5","author":"Sprague","year":"2024","journal-title":"Kidney360"},{"issue":"5","key":"10.1016\/j.xkme.2025.101237_bib29","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/ajg.2017.41","article-title":"Tenapanor treatment of patients with constipation-predominant irritable bowel syndrome: a phase 2, randomized, placebo-controlled efficacy and safety trial","volume":"112","author":"Chey","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"17","key":"10.1016\/j.xkme.2025.101237_bib30","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1007\/s40265-019-01215-9","article-title":"Tenapanor: first approval","volume":"79","author":"Markham","year":"2019","journal-title":"Drugs"},{"issue":"456","key":"10.1016\/j.xkme.2025.101237_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam6474","article-title":"Inhibition of sodium\/hydrogen exchanger 3 in the gastrointestinal tract by tenapanor reduces paracellular phosphate permeability","volume":"10","author":"King","year":"2018","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.xkme.2025.101237_bib34","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1186\/s12882-021-02600-x","article-title":"The CKD bowel health study: understanding the bowel health and gastrointestinal symptom management in patients with chronic kidney disease: a mixed-methods observational longitudinal study (protocol)","volume":"22","author":"Cooper","year":"2021","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.xkme.2025.101237_bib35","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.xkme.2025.101237_bib37","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/hdi.12315","article-title":"Phosphate binder pill burden, patient-reported non-adherence, and mineral bone disorder markers: findings from the DOPPS","volume":"20","author":"Fissell","year":"2016","journal-title":"Hemodial Int"},{"issue":"2","key":"10.1016\/j.xkme.2025.101237_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2022.100584","article-title":"Serum phosphorus level rises in US hemodialysis patients over the past decade: a DOPPS special report","volume":"5","author":"Guedes","year":"2022","journal-title":"Kidney Med"},{"issue":"9","key":"10.1016\/j.xkme.2025.101237_bib40","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3109\/00365529709011203","article-title":"Stool form scale as a useful guide to intestinal transit time","volume":"32","author":"Lewis","year":"1997","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"10.1016\/j.xkme.2025.101237_bib41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.15537\/smj.2015.1.9843","article-title":"Hyperphosphatemia. The hidden killer in chronic kidney disease","volume":"36","author":"Askar","year":"2015","journal-title":"Saudi Med J"},{"issue":"6","key":"10.1016\/j.xkme.2025.101237_bib42","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2215\/CJN.00290109","article-title":"Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients","volume":"4","author":"Chiu","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2025.101237_bib44","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1053\/j.ajkd.2020.05.025","article-title":"State-of-the-art management of hyperphosphatemia in patients with CKD: an NKF-KDOQI controversies perspective","volume":"77","author":"Scialla","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.xkme.2025.101237_bib45","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.semnephrol.2012.12.018","article-title":"Management of natural and added dietary phosphorus burden in kidney disease","volume":"33","author":"Cupisti","year":"2013","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.xkme.2025.101237_bib46","series-title":"2022 USRDS Annual Data Report: Epidemiology of kidney disease in the United States","year":"2022"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059525002730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059525002730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:22:17Z","timestamp":1784067737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059525002730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2590059525002730"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2025.101237","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Impact of Tenapanor on Serum Phosphate in Adult Dialysis Patients: A Narrative Review","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2025.101237","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101237"}}